New program aims to stop dangerous low blood sugar in diabetes patients

NCT ID NCT06353217

Completed Knowledge-focused Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a new program to help prevent low blood sugar (hypoglycemia) in people with diabetes who take medications that can cause it. The program included a patient survey and a toolkit for doctors. The study involved 35 patients and their primary care providers at one clinic. The main goal was to see if the program was acceptable and practical for use in a busy primary care setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hypoglycemia Prevention Program (patient survey and provider toolkit)
What this could lead to: If this program works well, it could lead to a larger study and eventually a simple way for doctors to help patients avoid dangerous low blood sugar episodes.
What could go wrong: This is a very small pilot study with only 35 people, so results may not apply to everyone. It focuses on whether the program is acceptable, not yet on whether it actually prevents low blood sugar.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypoglycemia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS HYPOGLYCEMIA

Contacts and locations

Locations

Johns Hopkins University School of Medicine

Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.